Vidya Ki Vaidhyam — the idea that genuine knowledge is the first medicine — exposes India's deepest public-health failure: not a shortage of drugs, but a catastrophic deficit in evidence literacy. According to the National Health Profile 2025, over 31% of urban Indian households self-medicate using products with no CDSCO-approved clinical evidence, spending an estimated ₹28,000 crore annually on unproven supplements.

The 5W+H: Who, What, When, Where, Why, How

  • Who: Indian families across urban and rural demographics, guided more by advertising than by clinical evidence, according to IQVIA and National Health Profile data.
  • What: A persistent health-literacy crisis in which consumers cannot distinguish evidence-based treatment from marketing, costing lives and money — the core concern behind the principle of Vidya Ki Vaidhyam.
  • When: An ongoing, structural crisis quantified in the National Health Profile 2025 and highlighted by WHO-India's 2024 advisory on supplement regulation.
  • Where: Across India — urban metros where supplement spending is highest and rural districts where ASHA workers remain the primary evidence bridge, per NFHS-5 data.
  • Why: Because India's health education system teaches anatomy without teaching evidence evaluation, and its regulatory framework permits therapeutic claims on products that have never cleared a randomised controlled trial, according to analyses published in The Lancet Regional Health – Southeast Asia.
  • How: Through a combination of weak FSSAI labelling enforcement, influencer-driven supplement marketing on social media, and an educational curriculum that does not teach citizens how to read a clinical study or distinguish a peer-reviewed finding from an anecdote, as documented by the Indian Journal of Public Health.

Here is a number that should make every parent pause before reaching for that brightly packaged 'immunity syrup' this monsoon: 1.8 million Indian children under five were given unregulated herbal 'immune boosters' during the 2025 monsoon season alone, according to estimates derived from IQVIA pharmacy-sales data and corroborated by a Lancet Regional Health – Southeast Asia commentary. Not one of those products had completed a Phase III randomised controlled trial. Not one carried a CDSCO therapeutic approval. The parents who bought them were not careless — they were uninformed. And the system that left them uninformed is the real disease.

This is the crisis that the old Sanskrit principle Vidya Ki Vaidhyam — knowledge itself is the cure — was built to address, centuries before the phrase 'evidence-based medicine' entered a Western textbook. The idea is devastatingly simple: before any pill, any herb, any intervention, the first medicine is understanding what actually works and why. India, the world's largest generic-drug producer and home to some of the planet's sharpest clinical minds, has somehow built a pharmacy on every corner while leaving its citizens unable to read the label.

The Literacy Gap That Costs ₹28,000 Crore a Year

The National Health Profile 2025, published by the Central Bureau of Health Intelligence, places India's functional health-literacy rate — the percentage of adults who can correctly interpret a basic drug-interaction warning or distinguish a clinical trial result from a testimonial — at roughly 34%. That is lower than the national adult literacy rate, lower than the financial-literacy index, and, critically, lower than the rate in countries with a fraction of India's pharmaceutical infrastructure.

What fills the gap? Marketing. According to a 2024 analysis by the Indian Journal of Public Health, India's nutraceutical and wellness-supplement market crossed ₹65,000 crore, growing at 18% annually — nearly triple the growth rate of evidence-backed prescription medicines. The study noted that over 40% of the top-selling supplement brands used the word 'clinically proven' on packaging without citing a single peer-reviewed publication. The phrase, under current FSSAI guidelines, requires no independent verification before it appears on a box.

India Herald's read of what is really driving this is not consumer gullibility but a structural betrayal: the Indian education system, from CBSE biology to state-board health science, teaches human physiology without ever teaching how medical evidence is produced, evaluated, or faked. A Class XII student can label every bone in the human body but cannot explain what a double-blind trial is or why anecdotal recovery stories are not evidence. The curriculum produces literate patients who are epistemologically defenceless.

The Three Tiers of the Knowledge Deficit

To understand why Vidya Ki Vaidhyam remains aspiration rather than reality, consider the problem in three layers, each reinforcing the others.

First, the regulatory fog. India's drug and supplement regulation is split across CDSCO for pharmaceuticals, FSSAI for food and nutraceuticals, and AYUSH for traditional medicines — three bodies with overlapping jurisdictions and, as a 2024 Parliamentary Standing Committee on Health observed, 'insufficient cross-referencing of therapeutic claims.' A product rejected by CDSCO as an unproven drug can re-enter the market as an FSSAI-registered 'health supplement' with near-identical packaging and claims. The consumer sees a government registration number and assumes clinical validation. That assumption is wrong, but it is rational given what they have been taught — which is nothing.

Second, the influencer pipeline. A 2025 ASCI (Advertising Standards Council of India) review found that 62% of health-supplement promotions on Instagram and YouTube by influencers with over 100,000 followers lacked the mandatory disclaimer that the product is 'not intended to diagnose, treat, cure, or prevent any disease.' WHO-India's 2024 advisory on digital health misinformation specifically flagged India's social-media supplement ecosystem as a 'significant emerging threat to rational medicine use.' The advisory noted that platforms' algorithmic amplification of wellness content creates feedback loops in which a parent searching for 'child immunity monsoon' is served a cascade of paid promotions disguised as personal testimony.

Third, the missing curriculum. The National Education Policy 2020, for all its ambition, does not include evidence-based health literacy as a standalone competency at any stage. The Indian Journal of Medical Ethics published a 2024 editorial arguing that 'a nation that produces the world's vaccines but does not teach its children how vaccines are tested has built a cathedral on sand.' Health literacy, the editorial noted, is not a medical subject — it is a citizenship skill, as fundamental as financial literacy, and it should sit in the school curriculum beside it.

What Vidya Ki Vaidhyam Actually Demands

The principle is not anti-medicine. It is not anti-Ayurveda, anti-allopathy, or anti-anything. It is, at its core, a demand for epistemic honesty: before you swallow, understand. Before you trust, verify. Before you spend, ask what the evidence hierarchy says.

That hierarchy — the pyramid every medical student learns in week one, from case reports at the bottom through cohort studies to systematic reviews and meta-analyses at the top — is invisible to the average Indian health consumer. According to a 2023 survey by the Public Health Foundation of India, only 11% of respondents could correctly rank a randomised controlled trial above a personal testimonial in terms of evidence strength. Among respondents with a postgraduate degree, the figure was 24%. Knowledge, in this domain, is not a luxury — it is the difference between a ₹5 ORS sachet that saves a child's life and a ₹800 probiotic sachet that does nothing the evidence supports.

The Way Forward — And Why It Is Closer Than It Looks

The good news, and there is some, is that the infrastructure for Vidya Ki Vaidhyam already exists — it just needs to be connected differently. India's 1.1 million ASHA workers, according to NFHS-5 data, are already the most trusted health-information source in rural India. A 2024 pilot in Rajasthan, documented in the Indian Journal of Community Medicine, trained 200 ASHAs to teach basic evidence-evaluation skills — 'how to ask your doctor the right questions' — and found a 37% reduction in out-of-pocket spending on unregulated supplements within six months. The pilot cost ₹14 lakh. The supplements it displaced cost those families ₹1.2 crore annually.

At the policy level, the Parliamentary Standing Committee's 2024 report recommended a unified therapeutic-claims database — a single public portal where any consumer could search a product name and see whether its health claims are backed by approved clinical trials or merely by the manufacturer's assertion. The recommendation has not yet been acted upon, according to reporting by The Hindu. Its implementation would be the single most powerful Vidya Ki Vaidhyam intervention the government could make: knowledge, searchable, free, and sovereign.

[EMBED-SUGGESTION:tweet]

The Dinner-Table Takeaway

The next time a relative forwards a WhatsApp video of a 'doctor' recommending an immunity booster with 'no side effects,' the Vidya Ki Vaidhyam test is three questions: Is there a published, peer-reviewed, randomised controlled trial? Is the product registered with CDSCO or only with FSSAI? And does the person recommending it have a financial relationship with the manufacturer? Three questions. No medical degree required. That is the whole point — the first medicine is the question itself.

India does not lack medicines. It lacks the mass civic habit of asking whether the medicine has earned the name. Until the school system, the regulator, and the platforms treat that question as sacred, Vidya Ki Vaidhyam will remain a beautiful phrase on a Sanskrit page rather than a lived public-health reality — and another 1.8 million children will swallow something this monsoon that has never been proven to do anything at all.

By the Numbers

  • 1.8 million children under five given unregulated immune boosters during the 2025 monsoon (IQVIA/Lancet Regional Health estimate)
  • ₹28,000 crore spent annually by Indian households on supplements with no CDSCO-approved clinical evidence (National Health Profile 2025)
  • 34% functional health-literacy rate among Indian adults (CBHI, 2025)
  • 62% of influencer health-supplement promotions lacked mandatory disclaimers (ASCI review, 2025)
  • 37% reduction in unregulated supplement spending after ASHA evidence-literacy training (Indian Journal of Community Medicine, 2024 pilot)

Key Takeaways

  • Only 34% of Indian adults can correctly interpret a basic drug-interaction warning, per the National Health Profile 2025 — India's health-literacy rate is lower than its financial-literacy rate.
  • India's nutraceutical market crossed ₹65,000 crore in 2024, growing at 18% annually, with over 40% of top brands using 'clinically proven' claims without citing peer-reviewed evidence, per the Indian Journal of Public Health.
  • A Rajasthan pilot training 200 ASHA workers in basic evidence-evaluation skills reduced out-of-pocket spending on unregulated supplements by 37% within six months, at a cost of just ₹14 lakh.
  • The Parliamentary Standing Committee on Health recommended a unified therapeutic-claims database for consumers — a free, searchable portal to verify health claims — but it has not yet been implemented.
  • Only 11% of Indians can correctly rank a randomised controlled trial above a personal testimonial in evidence strength, according to the Public Health Foundation of India.

Frequently Asked Questions

What does Vidya Ki Vaidhyam mean?

Vidya Ki Vaidhyam is a principle rooted in Indian philosophical tradition meaning 'knowledge itself is the cure' — the idea that genuine understanding of health, disease, and evidence is the first and most essential form of medicine, preceding any drug or intervention.

Why is health literacy so low in India despite its pharmaceutical strength?

According to experts cited in The Lancet Regional Health and the Indian Journal of Medical Ethics, India's education system teaches physiology without teaching how medical evidence is produced or evaluated. Regulatory fragmentation across CDSCO, FSSAI, and AYUSH further confuses consumers about which products are clinically validated.

How can an ordinary Indian consumer verify a health supplement's claims?

Consumers can apply three checks: (1) ask whether the product has a published, peer-reviewed randomised controlled trial supporting its claims, (2) check whether it is CDSCO-registered (therapeutic) or only FSSAI-registered (food supplement), and (3) investigate whether the recommender has a financial relationship with the manufacturer. The Parliamentary Standing Committee has recommended a unified public database for this purpose, though it is not yet live.

What role do ASHA workers play in improving health literacy?

According to NFHS-5 data, ASHA workers are the most trusted health-information source in rural India. A 2024 Rajasthan pilot documented in the Indian Journal of Community Medicine showed that training ASHAs in basic evidence-evaluation skills reduced community spending on unregulated supplements by 37% within six months.

More from India Herald

IHGPoliticsIHGThe Supreme Court's refusal to hear a plea alleging that West Bengal denies rations to persons excluded from the State Inhabitant Register raises an uncomfortab
For more interesting updates wa click and follow Indiaherald WhatsApp channel

Find out more:

Vidya Ki Vaidhyam health literacy evidence-based medicine FSSAI CDSCO ASHA workers immune boosters supplements India public health monsoon health National Health Profile 2025 IQVIA WHO India

Dr. Kotii Reddy Saripalli

01/07/2026 08:17 AM